Neuland Laboratories Ltd (NEUL)

BSE
Currency in INR
12,228.65
-5.75(-0.05%)
Closed·
NEUL Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
NEUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12,125.3012,644.40
52 wk Range
6,552.0018,089.55
Key Statistics
Edit
Bid/Ask
12,245.00 / 12,285.00
Prev. Close
12,234.4
Open
12,215
Day's Range
12,125.3-12,644.4
52 wk Range
6,552-18,089.55
Volume
2.52K
Average Volume (3m)
3.4K
1-Year Change
86.95%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEUL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15,517.50
Upside
+26.89%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Neuland Laboratories Ltd News & Analysis

Show more

Neuland Laboratories Ltd Company Profile

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
1643
Market
India

Compare NEUL to Peers and Sector

Metrics to compare
NEUL
Peers
Sector
Relationship
P/E Ratio
60.3x29.9x−0.5x
PEG Ratio
−4.530.770.00
Price/Book
10.3x3.2x2.6x
Price / LTM Sales
10.6x4.4x3.0x
Upside (Analyst Target)
26.9%10.1%52.6%
Fair Value Upside
Unlock−8.6%8.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15,517.50
(+26.89% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 202.74%
Dividend Yield
0.10%
Industry Median 0.69%
Annualised payout
12.00
Paid annually
5-Years Growth
+43.10%
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
21.64 / 39.00
Revenue / Forecast
3.28B / 3.66B
EPS Revisions
Last 90 days

NEUL Income Statement

FAQ

What Is the Neuland Laboratories Ltd (NEUL) Stock Price Today?

The Neuland Laboratories Ltd stock price today is 12,228.65.

What Stock Exchange Does Neuland Laboratories Ltd Trade On?

Neuland Laboratories Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Neuland Laboratories Ltd?

The stock symbol for Neuland Laboratories Ltd is "NEUL."

Does Neuland Laboratories Ltd Pay Dividends? What’s The Current Dividend Yield?

The Neuland Laboratories Ltd dividend yield is 0.1%.

What Is the Neuland Laboratories Ltd Market Cap?

As of today, Neuland Laboratories Ltd market cap is 156.89B.

What Is Neuland Laboratories Ltd's Earnings Per Share (TTM)?

The Neuland Laboratories Ltd EPS (TTM) is 202.74.

When Is the Next Neuland Laboratories Ltd Earnings Date?

Neuland Laboratories Ltd will release its next earnings report on 30 Jul 2025.

From a Technical Analysis Perspective, Is NEUL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Neuland Laboratories Ltd Stock Split?

Neuland Laboratories Ltd has split 2 times.

How Many Employees Does Neuland Laboratories Ltd Have?

Neuland Laboratories Ltd has 1643 employees.

What is the current trading status of Neuland Laboratories Ltd (NEUL)?

As of 21 Jun 2025, Neuland Laboratories Ltd (NEUL) is trading at a price of 12,228.65, with a previous close of 12,234.40. The stock has fluctuated within a day range of 12,125.30 to 12,644.40, while its 52-week range spans from 6,552.00 to 18,089.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.